BR0208920A - Inibidor de aromatase em dose única para tratamento de infertilidade - Google Patents
Inibidor de aromatase em dose única para tratamento de infertilidadeInfo
- Publication number
- BR0208920A BR0208920A BR0208920-3A BR0208920A BR0208920A BR 0208920 A BR0208920 A BR 0208920A BR 0208920 A BR0208920 A BR 0208920A BR 0208920 A BR0208920 A BR 0208920A
- Authority
- BR
- Brazil
- Prior art keywords
- aromatase inhibitor
- single dose
- infertility
- medicament
- fsh
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"INIBIDOR DE AROMATASE EM DOSE úNICA PARA TRATAMENTO DE INFERTILIDADE". Uso de um inibidor de aromatase (Ais) na preparação de um medicamento para ser usado para induzir a ovulação em fêmeas sofrendo de infertilidade anovulatória que compreende administrar às referidas fêmeas uma dose única de pelo menos um inibidor de aromatase. Uso de um inibidor de aromatase (AI) na preparação de um medicamento compreendendo uma dose única de pelo menos um inibidor de aromatase (AI) para ser administrado a uma fêmea ovulatória sofrendo de infertilidade inexplicada ou outros tipos de infertilidade ovulatória no início de um ou mais ciclos menstruais. Tal medicamento também pode ser administrado a uma fêmea anovulatória em combinação com uma pluralidade de doses diárias de hormónio foliculoestimulante (FSH), pelo que os níveis de dosagem do FSH podem ser reduzidos. Também está descrito o uso de um Al na preparação de um medicamento para ser administrado a uma fêmea que seja pouco sensível a FSH, que compreende uma combinação de uma dose única de Al com uma pluralidade de doses diárias de FSH. Também estão descritas preparações e embalagens farmacêuticas relacionadas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28428201P | 2001-04-17 | 2001-04-17 | |
PCT/CA2002/000527 WO2002083241A1 (en) | 2001-04-17 | 2002-04-17 | Single dose aromatase inhibitor for treating infertility |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0208920A true BR0208920A (pt) | 2004-04-20 |
Family
ID=23089583
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0208920-3A BR0208920A (pt) | 2001-04-17 | 2002-04-17 | Inibidor de aromatase em dose única para tratamento de infertilidade |
Country Status (32)
Country | Link |
---|---|
US (1) | US8008333B2 (pt) |
EP (1) | EP1383578B1 (pt) |
JP (1) | JP2004529924A (pt) |
KR (1) | KR20040025916A (pt) |
CN (1) | CN1551789A (pt) |
AR (1) | AR034036A1 (pt) |
AT (1) | ATE409066T1 (pt) |
AU (1) | AU2002249043B2 (pt) |
BG (1) | BG108323A (pt) |
BR (1) | BR0208920A (pt) |
CA (1) | CA2444980C (pt) |
CY (1) | CY1108648T1 (pt) |
CZ (1) | CZ20033107A3 (pt) |
DE (1) | DE60229047D1 (pt) |
DK (1) | DK1383578T3 (pt) |
EA (1) | EA011310B1 (pt) |
EE (1) | EE200300505A (pt) |
ES (1) | ES2311599T3 (pt) |
HR (1) | HRP20030839A2 (pt) |
HU (1) | HUP0304003A2 (pt) |
IL (1) | IL158396A0 (pt) |
MX (1) | MXPA03009447A (pt) |
NO (1) | NO20034246L (pt) |
NZ (1) | NZ552873A (pt) |
PL (1) | PL366744A1 (pt) |
PT (1) | PT1383578E (pt) |
SI (1) | SI1383578T1 (pt) |
SK (1) | SK14242003A3 (pt) |
UA (1) | UA82648C2 (pt) |
WO (1) | WO2002083241A1 (pt) |
YU (1) | YU81203A (pt) |
ZA (1) | ZA200307516B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004004634A2 (en) * | 2002-07-02 | 2004-01-15 | Pharmacia & Upjohn Company Llc | Infertility treatment with exemestane |
WO2007000056A1 (en) * | 2005-06-28 | 2007-01-04 | Casper Robert F | Aromatase inhibitors for emergency contraception |
AU2007204969A1 (en) * | 2006-01-10 | 2007-07-19 | Cortendo Invest Ab | Methods and compositions for treating prostate cancer |
US9144569B2 (en) | 2010-05-20 | 2015-09-29 | University Of Saskatchewan | Methods of administering an aromatase inhibitor, prostaglandin and GnRH for regulating ovulation in cattle |
US10004723B2 (en) | 2013-04-19 | 2018-06-26 | University Of Saskatchewan | Aromatase inhibitor-releasing intravaginal device |
US20160022644A1 (en) * | 2014-07-22 | 2016-01-28 | Tsu-I Catherine Wang | Oral Transmucosal Compositions Including Aromatase Inhibitors for Treating Female Infertility |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4728645A (en) * | 1982-12-21 | 1988-03-01 | Ciba-Geigy Corporation | Substituted imidazo[1,5-A]pyridine derivatives and other substituted bicyclic derivatives, useful as aromatase inhibitors |
US4845227A (en) * | 1984-06-18 | 1989-07-04 | Eli Lilly And Company | Aromatase inhibitors from azoles |
US4602025A (en) * | 1984-06-18 | 1986-07-22 | Eli Lilly And Company | Aromatase inhibitors |
US4978672A (en) * | 1986-03-07 | 1990-12-18 | Ciba-Geigy Corporation | Alpha-heterocyclc substituted tolunitriles |
GB8726505D0 (en) * | 1987-11-12 | 1987-12-16 | Ici Plc | Naphtho(2 1-b)furan derivatives |
DE4330237C2 (de) | 1993-09-02 | 1995-11-30 | Schering Ag | 1-Methylsubstituierte Androsta-1,4-dien-3,17-dione, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate |
EP0906115A1 (en) * | 1996-04-30 | 1999-04-07 | Takeda Chemical Industries, Ltd. | COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
DE19622457A1 (de) | 1996-05-24 | 1997-11-27 | Schering Ag | 7alpha-(5-Methylaminopentyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha-(5-Methylaminopentyl)-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
US6953774B2 (en) * | 2000-08-11 | 2005-10-11 | Applied Research Systems Ars Holding N.V. | Methods of inducing ovulation |
-
2002
- 2002-04-17 DE DE60229047T patent/DE60229047D1/de not_active Expired - Lifetime
- 2002-04-17 SI SI200230747T patent/SI1383578T1/sl unknown
- 2002-04-17 UA UA20031110268A patent/UA82648C2/uk unknown
- 2002-04-17 BR BR0208920-3A patent/BR0208920A/pt not_active IP Right Cessation
- 2002-04-17 AT AT02717919T patent/ATE409066T1/de active
- 2002-04-17 ES ES02717919T patent/ES2311599T3/es not_active Expired - Lifetime
- 2002-04-17 CZ CZ20033107A patent/CZ20033107A3/cs unknown
- 2002-04-17 SK SK1424-2003A patent/SK14242003A3/sk unknown
- 2002-04-17 MX MXPA03009447A patent/MXPA03009447A/es not_active Application Discontinuation
- 2002-04-17 YU YU81203A patent/YU81203A/sh unknown
- 2002-04-17 CA CA2444980A patent/CA2444980C/en not_active Expired - Fee Related
- 2002-04-17 AR ARP020101399A patent/AR034036A1/es unknown
- 2002-04-17 NZ NZ552873A patent/NZ552873A/en not_active IP Right Cessation
- 2002-04-17 PL PL02366744A patent/PL366744A1/xx not_active Application Discontinuation
- 2002-04-17 KR KR10-2003-7013484A patent/KR20040025916A/ko not_active Application Discontinuation
- 2002-04-17 HU HU0304003A patent/HUP0304003A2/hu unknown
- 2002-04-17 WO PCT/CA2002/000527 patent/WO2002083241A1/en active IP Right Grant
- 2002-04-17 EP EP02717919A patent/EP1383578B1/en not_active Expired - Lifetime
- 2002-04-17 EA EA200301128A patent/EA011310B1/ru not_active IP Right Cessation
- 2002-04-17 EE EEP200300505A patent/EE200300505A/xx unknown
- 2002-04-17 CN CNA028120825A patent/CN1551789A/zh active Pending
- 2002-04-17 US US10/475,101 patent/US8008333B2/en not_active Expired - Fee Related
- 2002-04-17 IL IL15839602A patent/IL158396A0/xx unknown
- 2002-04-17 PT PT02717919T patent/PT1383578E/pt unknown
- 2002-04-17 DK DK02717919T patent/DK1383578T3/da active
- 2002-04-17 AU AU2002249043A patent/AU2002249043B2/en not_active Ceased
- 2002-04-17 JP JP2002581041A patent/JP2004529924A/ja active Pending
-
2003
- 2003-09-23 NO NO20034246A patent/NO20034246L/no not_active Application Discontinuation
- 2003-09-26 ZA ZA200307516A patent/ZA200307516B/en unknown
- 2003-10-15 HR HR20030839A patent/HRP20030839A2/hr not_active Application Discontinuation
- 2003-11-07 BG BG108323A patent/BG108323A/bg unknown
-
2008
- 2008-12-12 CY CY20081101446T patent/CY1108648T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9909672A (pt) | uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão | |
BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
NO964089D0 (no) | Farmasöytisk kombinasjonspreparat for hormonal konsentrasjon | |
BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
PT835114E (pt) | Preparado de combinacao farmaceutico kit e metodo para contracepcao hormonal | |
BRPI0108435B8 (pt) | formulação e uso de entecavir de baixa dose | |
MX173567B (es) | Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih | |
Wachstein et al. | Pyridoxal phosphate in plasma and leukocytes of normal and pregnant subjects following B6 load tests. | |
MY144021A (en) | Pharmaceutical delivery system | |
IT1255723B (it) | Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione | |
BR0208920A (pt) | Inibidor de aromatase em dose única para tratamento de infertilidade | |
EP0114003A1 (en) | Antiandrogen and antibiotic treatment of acne and pharmaceutical preparations therefor | |
SK94298A3 (en) | Composition containing diosgenin | |
BR0208955A (pt) | Inibidores de aromatase para tratamento de infertilidade | |
BR0107881A (pt) | Uso de fsh tratamento de infertilidade | |
EE03385B1 (et) | Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid | |
JP2004529924A5 (pt) | ||
BR9611671A (pt) | Método de alvejamento de dosagens de medicamentos e de agentes terapêuticos e de outros glicosaminoglicanos (gags) para tratar de uma doença ou condição em um ser humano. | |
AR034310A1 (es) | Inhibicion de aromatasa para mejorar la reproduccion asistida | |
Rozenbaum et al. | Efficacy and tolerability of pulsed estrogen therapy: a 12-week double-blind placebo-controlled study in highly symptomatic postmenopausal women | |
KR830008678A (ko) | 진통 조성물 | |
Levinson et al. | VagiSite bioadhesive technology | |
KR890701111A (ko) | 사람의 이상지혈증의 치료방법 | |
WO2021046446A1 (en) | Compositions and methods of use for enhancing fertility | |
BR9912260A (pt) | Emplastro contendo um sistema terapêutico transdérmico e dose única para ministração |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 8A E 9A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |
|
B15K | Others concerning applications: alteration of classification |
Ipc: A61K 31/56 (2006.01), A61P 15/00 (2006.01), A61P 5 |